Structure (Image 01)
Leucovorin Calcium Injection, Powder, Lyophilized, For Suspension
Product Images NDC 67457-528
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Leucovorin Calcium (NDC 67457-528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton 100 mg (Image 02)
Carton 200 mg (Image 03)
Leucovorin Calcium is a medication used for intravenous or intramuscular use. The package insert should be reviewed for full prescription information, as the solution contains acetic acid and sodium chloride. Dilution with USP-approved solutions is required, and unused portions should be discarded. The drug is protected from light and does not contain preservatives.*
300 mg Carton (Image 04)
Leucovorin Calcium is a lyophilized powder that is to be diluted and administered intravenously or intramuscularly for medical purposes. It comes in a 350 mg vial and contains Loucovorn Calcum which is equivalent to 10350 mg eucovorin, and 140 mg sodium chloride. It might contain additional substances like sodium yoroide ancior ycrocho acid for pH ausimer.' When the drug is reconstituted it contains 20 mg Loucovorn Calcium, USP in a volume of 17.6 mL sterile diluent per L of the prepared solution. It is manufactured by Mylan Institutional LLG in India and is available in a single use vial. It is important to refer to the package insert for complete prescribing information before use. The drug should not be used in doses greater than 10 mg/m (sc0 as per the warning on the package. The drug needs to be stored at 20°C to 25°C (68° to 77°F) and must be protected from light. Unused portions of the reconstituted drug should be discarded, and the drug should not be used if the vial's contents have been compromised.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
